New IVF 'Lab In A Box' Increases Clinical Pregnancy Rates By 50%
European launch of Ac-tive IVF System at ESHRE 2008, Barcelona
Pencoed, UK - Ruskinn Life Sciences is heralding a breakthrough in IVF treatment at the European Society of Human Reproduction and Embryology (ESHRE) annual conference with the unveiling of Ac-tive®, an innovative new technology capable of significantly boosting in-vitro fertilization (IVF) conception rates. The state-of-the-art gas controlled device mimics ‘in-utero' conditions for all IVF manipulations in a single workstation. According to Ruskinn, recent clinical trials in Denmark have demonstrated an increase in clinical pregnancy rates by up to 50% in an already successful IVF laboratory using the Ac-tive workstation.
According to the Human Fertilisation and Embryology Authority, the average IVF success rate (take home baby rate) for women under 35 years of age is 29.6%1. Using the Ac-tive IVF workstation, IVF clinics could potentially increase their "take home baby rate" by 50% - from a successful 29.6% to a possible 44.4%. Ac-tive results in the production of less stressed embryos, which suggests improved implantation in the uterus and ultimately increased pregnancy rates.
Due to the delicate nature of embryology, slight changes in the environmental conditions can greatly affect the IVF outcome. Research has shown that the development of oocytes and embryos occurs best in low oxygen/high humidity atmospheres at stable temperatures 2, 3 – something that is not always achieved in current IVF practice.
Ruskinn's unique Ac-tive workstation acts as a self-contained IVF laboratory, supporting the needs of embryologists performing a range of IVF manipulations Replicating the entire in-utero environment in a single, controlled-atmosphere workstation, Ac-tive delivers a stable, optimal atmosphere which simulates the environment of the human body and creates optimal conditions for embryo culture. This means all IVF procedures – from oocyte retrieval through to embryo transfer, and including embryo culture and selection - take place in a single, stable biological atmosphere.
The Ezee Sleeve Bare-hand System provides ‘hands in' access to the workstation, enabling all processes to be carried out without disturbing the carefully controlled environment. Thus Ac-tive assists compliance with the EU Tissues and Cells Directive (2004/23/EU).
The Ac-tive workstation incorporates Ruskinn's latest and most advanced gas mixing system enabling cells to be examined under precise O2 and CO2 tension in hepa filtered air. The touch screen user interface enables accurate atmospheric control with easy to interpret visual displays and intelligent environmental stability monitoring.
The small footprint of the Ac-tive IVF workstation releases valuable laboratory space by reducing the need for other gas controlled incubators and Class 2 biological safety cabinets. Ruskinn will be exhibiting the Ac-tive workstation at ESHRE from 6-9 July 2008.
About Ruskinn Technology Ltd/Ruskinn Life Sciences Ltd
The Ruskinn brand was founded in 1993 and rapidly became established as one of the world's leading suppliers of gas controlled, anaerobic and modified atmosphere workstations. In 2006, the independent Ruskinn Group of companies – Ruskinn Technology Limited and Ruskinn Life Sciences - was formed after a short transition period as part of Biotrace International.
Administration and production is sited at the ultra-modern Sony Pencoed plant in South Wales. Ruskinn is one of an elite group of UK medical companies offered the opportunity by Sony to co-locate and share the benefits of Sony's renowned production know-how and infrastructure.
Ruskinn products are available through a worldwide network of carefully selected distributors. Sales in Nordic Region and the US are made by Ruskinn's own staff.
SOURCE: Ruskinn Technology Ltd/Ruskinn Life Sciences Ltd